|
⚲
|
| Keyboard |
| Albers Jeffrey W
✚
|
|
|---|---|
| CIK # | 0001638474 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001638474] | |
| 4 | [0001638474] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Albers Jeffrey W | |
| Kymera Therapeutics Inc | |
| Spyre Therapeutics Inc | |
| Blueprint Medicines Corp | |
| Dianthus Therapeutics Inc /DE/ |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Kymera Therapeutics Inc KYMR
Common Stock
|
2025-12-08 | Sell | 2,252 | $90.30 | 203,356 |
|
Kymera Therapeutics Inc KYMR
Stock Option (Right to Buy) · derivative
|
2025-12-08 | Option exercise | 5,000 | $0.00 | |
|
Kymera Therapeutics Inc KYMR
Common Stock
|
2025-12-08 | Sell | 2,748 | $89.32 | 245,451 |
|
Kymera Therapeutics Inc KYMR
Common Stock
|
2025-12-08 | Option exercise | 5,000 | $14.18 | 70,900 |
|
Kymera Therapeutics Inc KYMR
Common Stock
|
2025-10-13 | Option exercise | 5,000 | $10.34 | 51,700 |
|
Kymera Therapeutics Inc KYMR
Common Stock
|
2025-10-13 | Sell | 5,000 | $59.19 | 295,950 |
|
Kymera Therapeutics Inc KYMR
Stock Option (Right to Buy) · derivative
|
2025-10-13 | Option exercise | 5,000 | $0.00 | |
|
Blueprint Medicines Corp BPMC
Common Stock
|
2025-07-17 | Disposed to issuer | 5,777 | ||
|
Blueprint Medicines Corp BPMC
Stock Option (Right to Buy) · derivative
|
2025-07-17 | Disposed to issuer | 90,000 | ||
|
Blueprint Medicines Corp BPMC
Common Stock
|
2025-07-17 | Tender | 144,755 | ||
|
Blueprint Medicines Corp BPMC
Stock Option (Right to Buy) · derivative
|
2025-07-17 | Disposed to issuer | 92,500 | ||
|
Blueprint Medicines Corp BPMC
Stock Option (Right to Buy) · derivative
|
2025-07-17 | Disposed to issuer | 170,000 | ||
|
Blueprint Medicines Corp BPMC
Stock Option (Right to Buy) · derivative
|
2025-07-17 | Disposed to issuer | 110,500 | ||
|
Blueprint Medicines Corp BPMC
Stock Option (Right to Buy) · derivative
|
2025-07-17 | Disposed to issuer | 4,570 | ||
|
Blueprint Medicines Corp BPMC
Stock Option (Right to Buy) · derivative
|
2025-07-17 | Disposed to issuer | 80,000 | ||
|
Blueprint Medicines Corp BPMC
Stock Option (Right to Buy) · derivative
|
2025-07-17 | Disposed to issuer | 15,000 | ||
|
Blueprint Medicines Corp BPMC
Stock Option (Right to Buy) · derivative
|
2025-07-17 | Disposed to issuer | 5,300 | ||
|
Kymera Therapeutics Inc KYMR
Stock Option (Right to Buy) · derivative
|
2025-06-25 | Grant | 16,000 | $0.00 | |
|
Blueprint Medicines Corp BPMC
Common Stock
|
2025-06-18 | Grant | 3,902 | $128.12 | 499,924 |
|
Kymera Therapeutics Inc KYMR
Common Stock
|
2025-06-03 | Option exercise | 6,349 | $10.34 | 65,649 |
| showing 20 of 200 most recent transactions | |||||